356 related articles for article (PubMed ID: 31237090)
1. Physical and biological impacts of collimator-scattered protons in spot-scanning proton therapy.
Ueno K; Matsuura T; Hirayama S; Takao S; Ueda H; Matsuo Y; Yoshimura T; Umegaki K
J Appl Clin Med Phys; 2019 Jul; 20(7):48-57. PubMed ID: 31237090
[TBL] [Abstract][Full Text] [Related]
2. An analytical dose-averaged LET calculation algorithm considering the off-axis LET enhancement by secondary protons for spot-scanning proton therapy.
Hirayama S; Matsuura T; Ueda H; Fujii Y; Fujii T; Takao S; Miyamoto N; Shimizu S; Fujimoto R; Umegaki K; Shirato H
Med Phys; 2018 Jul; 45(7):3404-3416. PubMed ID: 29788552
[TBL] [Abstract][Full Text] [Related]
3. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method.
Titt U; Zheng Y; Vassiliev ON; Newhauser WD
Phys Med Biol; 2008 Jan; 53(2):487-504. PubMed ID: 18185001
[TBL] [Abstract][Full Text] [Related]
4. An initial systematic study of the linear energy transfer distributions of a proton beam under a transverse magnetic field.
Fujii Y; Ueda H; Umegaki K; Matsuura T
Med Phys; 2022 Mar; 49(3):1839-1852. PubMed ID: 35124798
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity analysis of Monte Carlo model of a gantry-mounted passively scattered proton system.
Baradaran-Ghahfarokhi M; Reynoso F; Prusator MT; Sun B; Zhao T
J Appl Clin Med Phys; 2020 Feb; 21(2):26-37. PubMed ID: 31898873
[TBL] [Abstract][Full Text] [Related]
6. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code.
Guan F; Peeler C; Bronk L; Geng C; Taleei R; Randeniya S; Ge S; Mirkovic D; Grosshans D; Mohan R; Titt U
Med Phys; 2015 Nov; 42(11):6234-47. PubMed ID: 26520716
[TBL] [Abstract][Full Text] [Related]
8. Design and commissioning of the non-dedicated scanning proton beamline for ocular treatment at the synchrotron-based CNAO facility.
Ciocca M; Magro G; Mastella E; Mairani A; Mirandola A; Molinelli S; Russo S; Vai A; Fiore MR; Mosci C; Valvo F; Via R; Baroni G; Orecchia R
Med Phys; 2019 Apr; 46(4):1852-1862. PubMed ID: 30659616
[TBL] [Abstract][Full Text] [Related]
9. Exploration and application of phenomenological RBE models for proton therapy.
Rørvik E; Fjæra LF; Dahle TJ; Dale JE; Engeseth GM; Stokkevåg CH; Thörnqvist S; Ytre-Hauge KS
Phys Med Biol; 2018 Sep; 63(18):185013. PubMed ID: 30102240
[TBL] [Abstract][Full Text] [Related]
10. Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.
Pedersen J; Petersen JBB; Stokkevåg CH; Ytre-Hauge KS; Flampouri S; Li Z; Mendenhall N; Muren LP
Acta Oncol; 2017 Nov; 56(11):1413-1419. PubMed ID: 29037095
[TBL] [Abstract][Full Text] [Related]
11. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
12. Investigating the impact of alpha/beta and LET
Mara E; Clausen M; Khachonkham S; Deycmar S; Pessy C; Dörr W; Kuess P; Georg D; Gruber S
Med Phys; 2020 Aug; 47(8):3691-3702. PubMed ID: 32347564
[TBL] [Abstract][Full Text] [Related]
13. Validation of linear energy transfer computed in a Monte Carlo dose engine of a commercial treatment planning system.
Wagenaar D; Tran LT; Meijers A; Marmitt GG; Souris K; Bolst D; James B; Biasi G; Povoli M; Kok A; Traneus E; van Goethem MJ; Langendijk JA; Rosenfeld AB; Both S
Phys Med Biol; 2020 Jan; 65(2):025006. PubMed ID: 31801119
[TBL] [Abstract][Full Text] [Related]
14. Spot Scanning and Passive Scattering Proton Therapy: Relative Biological Effectiveness and Oxygen Enhancement Ratio in Cultured Cells.
Iwata H; Ogino H; Hashimoto S; Yamada M; Shibata H; Yasui K; Toshito T; Omachi C; Tatekawa K; Manabe Y; Mizoe JE; Shibamoto Y
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):95-102. PubMed ID: 27084632
[TBL] [Abstract][Full Text] [Related]
15. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
Traneus E; Ödén J
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
[TBL] [Abstract][Full Text] [Related]
16. Proton monoenergetic arc therapy (PMAT) to enhance LETd within the target.
Bertolet A; Carabe A
Phys Med Biol; 2020 Aug; 65(16):165006. PubMed ID: 32428896
[TBL] [Abstract][Full Text] [Related]
17. Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam.
Britten RA; Nazaryan V; Davis LK; Klein SB; Nichiporov D; Mendonca MS; Wolanski M; Nie X; George J; Keppel C
Radiat Res; 2013 Jan; 179(1):21-8. PubMed ID: 23148508
[TBL] [Abstract][Full Text] [Related]
18. Range uncertainty in proton therapy due to variable biological effectiveness.
Carabe A; Moteabbed M; Depauw N; Schuemann J; Paganetti H
Phys Med Biol; 2012 Mar; 57(5):1159-72. PubMed ID: 22330133
[TBL] [Abstract][Full Text] [Related]
19. Design of a focused collimator for proton therapy spot scanning using Monte Carlo methods.
Geoghegan TJ; Nelson NP; Flynn RT; Hill PM; Rana S; Hyer DE
Med Phys; 2020 Jul; 47(7):2725-2734. PubMed ID: 32170750
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the relative biological effectiveness of spot-scanning proton irradiation in vitro.
Maeda K; Yasui H; Matsuura T; Yamamori T; Suzuki M; Nagane M; Nam JM; Inanami O; Shirato H
J Radiat Res; 2016 Jun; 57(3):307-11. PubMed ID: 26838131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
